JPWO2020033903A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020033903A5 JPWO2020033903A5 JP2021531619A JP2021531619A JPWO2020033903A5 JP WO2020033903 A5 JPWO2020033903 A5 JP WO2020033903A5 JP 2021531619 A JP2021531619 A JP 2021531619A JP 2021531619 A JP2021531619 A JP 2021531619A JP WO2020033903 A5 JPWO2020033903 A5 JP WO2020033903A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- poly
- particles
- subject
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 58
- 239000002245 particle Substances 0.000 claims 27
- 229920000642 polymer Polymers 0.000 claims 24
- 229920001710 Polyorthoester Polymers 0.000 claims 16
- 239000002745 poly(ortho ester) Substances 0.000 claims 15
- 239000000969 carrier Substances 0.000 claims 13
- 239000000243 solution Substances 0.000 claims 13
- 239000003086 colorant Substances 0.000 claims 8
- 239000000049 pigment Substances 0.000 claims 8
- -1 poly(CPP) Polymers 0.000 claims 8
- 210000004207 Dermis Anatomy 0.000 claims 6
- 229920005576 aliphatic polyanhydride Polymers 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 6
- 238000006065 biodegradation reaction Methods 0.000 claims 5
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims 4
- 239000002202 Polyethylene glycol Substances 0.000 claims 4
- 229920005578 aromatic polyanhydride Polymers 0.000 claims 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 229920001223 polyethylene glycol Polymers 0.000 claims 4
- 206010057249 Phagocytosis Diseases 0.000 claims 3
- 229920000525 Poly[1,4-bis(hydroxyethyl)terephthalate-alt-ethyloxyphosphate]-co-1,4-bis(hydroxyethyl)terephthalate-co-terephthalate Polymers 0.000 claims 3
- 210000003491 Skin Anatomy 0.000 claims 3
- 238000004220 aggregation Methods 0.000 claims 3
- 230000002776 aggregation Effects 0.000 claims 3
- 229920001400 block copolymer Polymers 0.000 claims 3
- 230000008782 phagocytosis Effects 0.000 claims 3
- VBISQLWPGDULSX-UHFFFAOYSA-N 4-[3-(4-carboxyphenoxy)propoxy]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OCCCOC1=CC=C(C(O)=O)C=C1 VBISQLWPGDULSX-UHFFFAOYSA-N 0.000 claims 2
- 229920000513 Poly[1,4-bis(hydroxyethyl)terephthalate-alt-ethyloxyphosphate] Polymers 0.000 claims 2
- 229920000526 Poly[1,6-bis(p-carboxyphenoxy)hexane] Polymers 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 229920005579 aliphatic aromatic polyanhydride Polymers 0.000 claims 2
- 239000006172 buffering agent Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 238000004040 coloring Methods 0.000 claims 2
- 230000001747 exhibiting Effects 0.000 claims 2
- 239000003906 humectant Substances 0.000 claims 2
- 238000010348 incorporation Methods 0.000 claims 2
- 239000007764 o/w emulsion Substances 0.000 claims 2
- 239000003921 oil Substances 0.000 claims 2
- 239000002953 phosphate buffered saline Substances 0.000 claims 2
- 229920003191 poly(1,3-bis-p-carboxyphenoxypropane anhydride) Polymers 0.000 claims 2
- 229920001610 polycaprolactone Polymers 0.000 claims 2
- 239000004632 polycaprolactone Substances 0.000 claims 2
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 claims 2
- 229920005862 polyol Polymers 0.000 claims 2
- 150000003077 polyols Chemical class 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- ITEKDBLBCIMYAT-UHFFFAOYSA-N 4-[(4-carboxyphenoxy)methoxy]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OCOC1=CC=C(C(O)=O)C=C1 ITEKDBLBCIMYAT-UHFFFAOYSA-N 0.000 claims 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 229920002988 biodegradable polymer Polymers 0.000 claims 1
- 239000004621 biodegradable polymer Substances 0.000 claims 1
- 229920000359 diblock copolymer Polymers 0.000 claims 1
- 230000003628 erosive Effects 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 150000002739 metals Chemical class 0.000 claims 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims 1
- YOURXVGYNVXQKT-UHFFFAOYSA-N oxacycloundecane-2,11-dione Chemical compound O=C1CCCCCCCCC(=O)O1 YOURXVGYNVXQKT-UHFFFAOYSA-N 0.000 claims 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 1
- 229920000428 triblock copolymer Polymers 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862717584P | 2018-08-10 | 2018-08-10 | |
| US62/717,584 | 2018-08-10 | ||
| PCT/US2019/046021 WO2020033903A1 (fr) | 2018-08-10 | 2019-08-09 | Particules contenant des agents colorants et procédés pour les utiliser |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021534242A JP2021534242A (ja) | 2021-12-09 |
| JPWO2020033903A5 true JPWO2020033903A5 (fr) | 2022-08-18 |
Family
ID=69415687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531619A Pending JP2021534242A (ja) | 2018-08-10 | 2019-08-09 | 着色剤を含有する粒子及びその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210154107A1 (fr) |
| EP (1) | EP3833318A4 (fr) |
| JP (1) | JP2021534242A (fr) |
| CN (1) | CN113194907A (fr) |
| AU (1) | AU2019320082A1 (fr) |
| BR (1) | BR112021007900A2 (fr) |
| CA (1) | CA3108431A1 (fr) |
| IL (1) | IL280655A (fr) |
| MA (1) | MA53291A (fr) |
| SG (1) | SG11202101047RA (fr) |
| WO (1) | WO2020033903A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022174078A1 (fr) * | 2021-02-12 | 2022-08-18 | Ephemeral Solutions, Inc. | Particules contenant des agents colorants et procédés pour les utiliser |
| CN113786351A (zh) * | 2021-09-30 | 2021-12-14 | 江苏省中国科学院植物研究所 | 氯法齐明作为染发剂的新用途 |
| CN114318604B (zh) * | 2021-12-15 | 2022-11-18 | 苏州大学 | 一种光致变色混纺棉纱及其制备方法和应用 |
| WO2023178213A2 (fr) * | 2022-03-15 | 2023-09-21 | Ephemeral Solutions, Inc. | Méthodes de marquage d'un emplacement cible pour une procédure médicale |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2659554B1 (fr) * | 1990-03-16 | 1994-09-30 | Oreal | Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant. |
| EP0568651B1 (fr) * | 1991-02-01 | 2002-04-17 | Massachusetts Institute Of Technology | Melanges de polymeres biodegradables pour apport medicamenteux |
| US5543158A (en) * | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| EP0831796A1 (fr) * | 1995-06-07 | 1998-04-01 | University Of Southern California | Procede pour la reduction ou la prevention de la formation d'adherences post-chirurgicales a l'aide d'inhibiteurs de 5-lipoxydase |
| US6013122A (en) * | 1998-08-18 | 2000-01-11 | Option Technologies, Inc. | Tattoo inks |
| JP3817519B2 (ja) * | 2000-11-15 | 2006-09-06 | ロレアル | ポリマー粒子分散液と顔料分散液を含有する化粧品用組成物 |
| US20040253293A1 (en) * | 2003-06-16 | 2004-12-16 | Afshin Shafiee | Rate controlled release of a pharmaceutical agent in a biodegradable device |
| JP2007528393A (ja) * | 2004-03-11 | 2007-10-11 | カイセラ バイオファーマシューティカルズ， インコーポレイテッド | 皮膚の状態および毛の状態を予防および処置するための組成物および方法 |
| EP1929304A2 (fr) * | 2005-08-19 | 2008-06-11 | Freedom-2, LLC | Nanoparticules piegees dans des cellules ou des organites |
| US20090311295A1 (en) * | 2006-05-12 | 2009-12-17 | Edith Mathiowitz | Particles with high uniform loading of nanoparticles and methods of preparation thereof |
| MX2009003737A (es) * | 2006-10-05 | 2009-06-16 | Panacea Biotec Ltd | Composicion inyectable en deposito y su procedimiento de preparacion. |
| US8828419B2 (en) * | 2006-10-06 | 2014-09-09 | Cordis Corporation | Bioabsorbable device having encapsulated additives for accelerating degradation |
| WO2009149308A2 (fr) * | 2008-06-04 | 2009-12-10 | Seventh Sense Biosystems, Inc. | Compositions et procédés pour un diagnostic rapide en une seule étape |
| EP2306991B1 (fr) * | 2008-06-27 | 2019-12-25 | Tepha, Inc. | Administration injectable améliorée de microparticules et leurs compositions |
| US20120042882A1 (en) * | 2010-08-23 | 2012-02-23 | Massachusetts Institute Of Technology | Particles with charged surface domains |
| EP2642984B1 (fr) * | 2010-11-24 | 2017-01-11 | Nanyang Technological University | Procédé pour l'encapsulation de particules |
| US9149426B2 (en) * | 2012-02-15 | 2015-10-06 | University Of Tennessee Research Foundation | Nanoparticle composition and methods to make and use the same |
| US9072678B2 (en) * | 2013-03-14 | 2015-07-07 | Pathak Holdings Llc | Methods for local drug delivery by microinjection |
| RU2016133040A (ru) * | 2014-01-10 | 2018-02-14 | ЧАМБЕР ВОРКС, ЭлЭлСи | Персонализирующая субстанция для нанесения на кожу или добавления к татуировочным чернилам и способы ее получения |
| CN106232085A (zh) * | 2014-03-04 | 2016-12-14 | 塔格拉生物技术有限公司 | 含着色剂的微胶囊 |
| ES2887423T3 (es) * | 2015-04-07 | 2021-12-22 | Revotek Co Ltd | Composiciones para la impresión tridimensional basadas en células |
| WO2017177184A1 (fr) * | 2016-04-08 | 2017-10-12 | Ultra Ink, Inc. | Encre pour tatouage éliminable et son procédé de production |
| US10179179B2 (en) * | 2016-10-28 | 2019-01-15 | Nano And Advanced Materials Institute Limited | Magnetic nanoparticles for disease diagnostics |
-
2019
- 2019-08-09 CN CN201980066947.3A patent/CN113194907A/zh active Pending
- 2019-08-09 BR BR112021007900-9A patent/BR112021007900A2/pt unknown
- 2019-08-09 CA CA3108431A patent/CA3108431A1/fr active Pending
- 2019-08-09 WO PCT/US2019/046021 patent/WO2020033903A1/fr unknown
- 2019-08-09 SG SG11202101047RA patent/SG11202101047RA/en unknown
- 2019-08-09 EP EP19847474.4A patent/EP3833318A4/fr active Pending
- 2019-08-09 JP JP2021531619A patent/JP2021534242A/ja active Pending
- 2019-08-09 MA MA053291A patent/MA53291A/fr unknown
- 2019-08-09 AU AU2019320082A patent/AU2019320082A1/en active Pending
-
2021
- 2021-02-01 US US17/164,308 patent/US20210154107A1/en not_active Abandoned
- 2021-02-04 IL IL280655A patent/IL280655A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bugnicourt et al. | Interests of chitosan nanoparticles ionically cross-linked with tripolyphosphate for biomedical applications | |
| Ali et al. | A review on chitosan and its nanocomposites in drug delivery | |
| Priyadarshini et al. | PLGA nanoparticles as chlorhexidine-delivery carrier to resin-dentin adhesive interface | |
| Salama et al. | A novel method for preparing surface-modified fluocinolone acetonide loaded PLGA nanoparticles for ocular use: in vitro and in vivo evaluations | |
| US6589562B1 (en) | Multicomponent biodegradable bioadhesive controlled release system for oral care products | |
| Hood et al. | Nanocarriers for vascular delivery of antioxidants | |
| Cohen-Sela et al. | A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles | |
| Jeong et al. | Preparation of poly (DL‐lactide‐co‐glycolide) nanoparticles without surfactant | |
| Andronescu et al. | Nanostructures for drug delivery | |
| Rafiei et al. | Pharmacokinetic consequences of PLGA nanoparticles in docetaxel drug delivery | |
| A Aljuffali et al. | Nanomedicine as a strategy for natural compound delivery to prevent and treat cancers | |
| Gupta et al. | Drug delivery using nanocarriers: Indian perspective | |
| JP2018503736A5 (fr) | ||
| Prasad et al. | Nanocarrier-based drug delivery systems for bone cancer therapy: a review | |
| Talevi et al. | Applications of nanosystems to anticancer drug therapy (Part I. Nanogels, nanospheres, nanocapsules) | |
| Holban et al. | Materials for Biomedical Engineering: Nanomaterials-based Drug Delivery | |
| Birnbaum et al. | Molecular weight distribution changes during degradation and release of PLGA nanoparticles containing epirubicin HCl | |
| JPWO2020033903A5 (fr) | ||
| JP5496684B2 (ja) | 局所使用のためのナノ粒子状麻酔薬組成物 | |
| Mudhakir et al. | Encapsulation of risperidone into chitosan-based nanocarrier via ionic binding interaction | |
| Elizabeth et al. | Nanoparticles as dental drug-delivery systems | |
| Niamprem et al. | Development and characterization of indomethacin-loaded mucoadhesive nanostructured lipid carriers for topical ocular delivery | |
| Kumari et al. | Nanomaterials: a promising tool for drug delivery | |
| WO2005002550A1 (fr) | Nanoparticules de derives polyoxyethylenes | |
| KR102269990B1 (ko) | 자외선 차단용 복합구조체 및 이의 제조방법 |